<DOC>
	<DOCNO>NCT01251185</DOCNO>
	<brief_summary>Evaluation non-invasive treatment modality , use low-intensity extracorporeal shockwaves treatment subject diagnose Congestive Heart Failure , ischemic etiology .</brief_summary>
	<brief_title>Extracorporeal Shockwave Myocardial Revascularization ( ESMR ) Therapy For The Treatment Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Patient male female 18 year old . 2 . Patient diagnose Heart Failure ischemic etiology . Diagnosis base medical history , complete physical evaluation , echocardiography . 3 . Patient document myocardial segment impaired contractility . Diagnosis base Rest Echo . 4 . Patient diagnose 50 % segment akinetic dyskinetic Diagnosis base echocardiography . 5 . Patient classify NYHA II IV . 6 . Patient stable dosage medication least 6 week prior enrollment . 7 . Patients Ejection Fraction &lt; 50 % . 8 . Patient stable without clinical event &gt; 3 month . 9 . Patient sign informed consent form . 10 . Patient 's condition stable life expectancy &gt; 12 month . 11 . Patient 's current past medical condition status assess use previous medical history , physical evaluation , physician ( principle investigator 's ) medical opinion . 1 . Patient intraventricular thrombus . 2 . Severe COPD ( patient FEV1 less .8 liter ) . 3 . Patient chronic lung disease include emphysema pulmonary fibrosis . 4 . Patient active endocarditis , myocarditis pericarditis . 5 . Patient simultaneously participate another device drug study , participate clinical trial involve experimental device drug , include drug device enhance cardiac neovascularization ESWT machine neovascularization competitor company within 3 month entry study . 6 . Patients unwilling unable cooperate study procedure . 7 . Patients unwilling quit smoking study procedure ( include screen phase ) . 8 . Patients diagnose severe valvular disease ( regurgitation stenosis ) . 9 . Patient pregnant . 10 . Patient malignancy area treatment without complete remission within 5 year ( lung , thorax , rib ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Extracorporeal Shockwave Therapy</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Non-invasive</keyword>
	<keyword>Device Trial</keyword>
	<keyword>NYHA ( New York Heart Association )</keyword>
	<keyword>Ischemic cardiomyopathy</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Myocardial contractility</keyword>
</DOC>